Adding Rocklatan to lower pressure after glaucoma stent surgery
Part of Eyes & vision clinical trials.
This study tests whether adding Rocklatan (a combination eye drop) after a Hydrus microstent procedure further reduces eye pressure in people with mild to moderate open-angle glaucoma. If it works, it could help keep your pressure in a safe range.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 40 years or older.
- You need mild to moderate open-angle glaucoma.
- You must have had cataract surgery with a Hydrus microstent (a tiny device that helps drain fluid) at least 3 months ago but within the last 2 years, with no other eye surgeries.
- Your eye pressure (without taking pressure-lowering drops) must be between 16 and 26 mmHg.
- You cannot be allergic to Rocklatan (a combination eye drop used to lower pressure).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study enrolls people who have cataracts and primary open-angle glaucoma that is being treated with eye drops. It will look at how well the Hydrus microstent works after approval, especially for lowering eye pressure safely.
This trial is testing a small device called the PRESERFLO MicroShunt to lower eye pressure in people with open-angle glaucoma. It may be an option if your eye pressure stays high even with maximum eye drops.
This study compares a new combination eye drop (Rocklatan) to a standard one (Latanoprost) to see how well they control eye pressure over 24 hours. It may help people with open-angle glaucoma or high eye pressure find a more effective treatment.
This study compares two eye drops—Rocklatan and latanoprost—for people with open-angle glaucoma who have already had a laser treatment (DSLT). It tests whether one drop works better than the other at lowering eye pressure after the laser.
This study tests whether three different eye drop treatments (netarsudil, latanoprost, or both together) can improve blood flow to the white part of the eye and the retina. It may help people with high eye pressure or who are glaucoma suspects better understand how these treatments work.
This study tests a combination eye drop called Rocklatan to see how it affects blood flow in the back of the eye (retina) in people with early open-angle glaucoma. You'll use the drops and have special eye scans to measure blood flow.
Hear when a new Primary Open Angle Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.